Determination of Mirtazapine in Human Plasma by HPLC-MS and Bioavailability of Newly Developed Mirtazapine Tablets in Healthy Volunteers

Rong-shan LI,Li DING,Long-hai JIAN,Hong XIAO
2004-01-01
Journal of Chinese Pharmaceutical Sciences
Abstract:Aim To establish a sensitive and specific liquid chromatography-mass spectrometry method for determination of mirtazapine in human plasma and evaluation of its relative bioavailability. Methods After being alkalized by 25 %ammonia, mirtazapine in the plasma was extracted with n-hexane. Desloratadine was used as internal standard (IS). Solutes were separated on a C18 column with a mobile phase of methanol-ammonium acetate buffer (pH 3.5) (75:25). The flow and operated in selected ion monitoring (SIM) and positive-ionization mode using target ionsatm/z 266.2 for mirtazapine and m/z 311.2 for the IS. The fragmentor voltage was 90 V. A randomized cross-over study was performed in 20 healthy volunteers. In the two study periods, twenty healthy Chinese male subjects received a single oral dose of mirtazapine 30 mg.mL-1 . The parameters for mirtazapine test tablet and reference tablet were as follows: T1/2 (24.7 + 4.1) and (23.6 +clusion The established HPLC-MS method is rapid, sensitive and specific for the determination of mirtazapine in human plasma. The relative bioavailahility was 100.0% ± 10.8%.
What problem does this paper attempt to address?